Motoi N - Search Results

1

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.

Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Ferreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, Kris M, Jain D, Kim YT, Lopez-Rios F, Lu S, Mitsudomi T, Moreira A, Motoi N, Nicholson AG, Oliveira R, Papotti M, Pastorino U, Paz-Ares L, Pelosi G, Poleri C, Provencio M, Roden AC, Scagliotti G, Swisher SG, Thunnissen E, Tsao MS, Vansteenkiste J, Weder W, Yatabe Y. Travis WD, et al. Among authors: motoi n. J Thorac Oncol. 2020 May;15(5):709-740. doi: 10.1016/j.jtho.2020.01.005. Epub 2020 Jan 28. J Thorac Oncol. 2020. PMID: 32004713 Free PMC article. Review.

2

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.

Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B, Bromberg JF. Gao SP, et al. Among authors: motoi n. J Clin Invest. 2007 Dec;117(12):3846-56. doi: 10.1172/JCI31871. J Clin Invest. 2007. PMID: 18060032 Free PMC article.

3

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL, Travis WD. Motoi N, et al. Am J Surg Pathol. 2008 Jun;32(6):810-27. doi: 10.1097/PAS.0b013e31815cb162. Am J Surg Pathol. 2008. PMID: 18391747

4

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD. Yoshizawa A, et al. Among authors: motoi n. Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232. Epub 2011 Jan 21. Mod Pathol. 2011. PMID: 21252858 Free article.

5

Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.

Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Yanagitani N, Hoshi R, Satoh Y, Motoi N, Hamanaka W, Ishikawa Y, Mun M, Sakao Y, Okumura S, Nakagawa K, Horai T, Nishio M. Kudo K, et al. Among authors: motoi n. Lung Cancer. 2011 Dec;74(3):401-4. doi: 10.1016/j.lungcan.2011.03.019. Epub 2011 Apr 29. Lung Cancer. 2011. PMID: 21529988

6

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study.

Thunnissen E, Beasley MB, Borczuk AC, Brambilla E, Chirieac LR, Dacic S, Flieder D, Gazdar A, Geisinger K, Hasleton P, Ishikawa Y, Kerr KM, Lantejoul S, Matsuno Y, Minami Y, Moreira AL, Motoi N, Nicholson AG, Noguchi M, Nonaka D, Pelosi G, Petersen I, Rekhtman N, Roggli V, Travis WD, Tsao MS, Wistuba I, Xu H, Yatabe Y, Zakowski M, Witte B, Kuik DJ. Thunnissen E, et al. Among authors: motoi n. Mod Pathol. 2012 Dec;25(12):1574-83. doi: 10.1038/modpathol.2012.106. Epub 2012 Jul 20. Mod Pathol. 2012. PMID: 22814311 Free PMC article.

7

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.

Kadota K, Villena-Vargas J, Yoshizawa A, Motoi N, Sima CS, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. Kadota K, et al. Among authors: motoi n. Am J Surg Pathol. 2014 Apr;38(4):448-60. doi: 10.1097/PAS.0000000000000134. Am J Surg Pathol. 2014. PMID: 24472852 Free PMC article.

8

A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell line.

Kodama T, Motoi N, Ninomiya H, Sakamoto H, Kitada K, Tsukaguchi T, Satoh Y, Nomura K, Nagano H, Ishii N, Terui Y, Hatake K, Ishikawa Y. Kodama T, et al. Among authors: motoi n. J Thorac Oncol. 2014 Nov;9(11):1638-46. doi: 10.1097/JTO.0000000000000311. J Thorac Oncol. 2014. PMID: 25144242 Free article.

9

Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.

Kuroda H, Sakao Y, Mun M, Uehara H, Nakao M, Matsuura Y, Mizuno T, Sakakura N, Motoi N, Ishikawa Y, Yatabe Y, Nakagawa K, Okumura S. Kuroda H, et al. Among authors: motoi n. PLoS One. 2015 Aug 6;10(8):e0134674. doi: 10.1371/journal.pone.0134674. eCollection 2015. PLoS One. 2015. PMID: 26247881 Free PMC article.

10

Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer.

Kuroda H, Sakao Y, Mun M, Motoi N, Ishikawa Y, Nakagawa K, Yatabe Y, Okumura S. Kuroda H, et al. Among authors: motoi n. J Thorac Dis. 2016 May;8(5):795-802. doi: 10.21037/jtd.2016.03.30. J Thorac Dis. 2016. PMID: 27162652 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page